Immune system proteins and DNA

The term "Immune system proteins and DNA" is a broad, non-specific designation that encompasses a wide variety of distinct biological molecules rather than a single therapeutic target. Immune system proteins include diverse classes such as cytokines, antibodies, and major histocompatibility complex (MHC) molecules, which are essential for mediating and regulating immune responses (StatPearls, 2023). DNA serves as the primary carrier of genetic information and can be targeted by various agents, including alkylating drugs in oncology or through modern gene-editing technologies (PubMed, 2021). Because this term combines disparate molecular classes with vastly different biological roles and pharmacological interactions, it is considered an incorrect or overly broad target definition for drug discovery purposes. Specificity is a cornerstone of modern pharmacology, and therapeutic intervention typically requires focusing on a single protein or a specific genetic locus to achieve desired clinical outcomes while minimizing adverse effects (UniProt, 2024).

Not applicable as this is a broad category rather than a specific molecular target.